Beth Hibbs, RN, MPH Immunization Safety Office - Division Of Healthcare Quality Promotion, Centers for Disease Control and Prevention Vaccination Errors.

Slides:



Advertisements
Similar presentations
The Vaccine Adverse Event Reporting System: A Tool for Safety and Surveillance Jane Woo, MD, MPH Vaccine Safety Branch Division of Epidemiology Office.
Advertisements

1 Cover page Let’s Review Changes in CDC Recommendations in 2011 Carolee’s Corner January 2012 MPCA
Importance of Vaccine Safety Decreases in disease risks and increased attention on vaccine risks Public confidence in vaccine safety is critical Low tolerance.
Julianne Gee, MPH Immunization Safety Office
VACCINE SAFETY: 101 Pandemic Influenza Vaccine Safety Conference Atlanta, Georgia August 21, 2008.
Adolescent Vaccines What every parent needs to know!
Part II: Vaccine Administration. Objectives  Participants will gain knowledge and enhance skills of current immunization issues by: Identifying common.
Tom Shimabukuro, MD, MPH, MBA Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious.
Elaine R. Miller, RN, MPH Immunization Safety Office Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases.
Tom Shimabukuro, MD, MPH, MBA Immunization Safety Office Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious.
2011 North Carolina Immunization Conference August 2011 Iyabode Akinsanya-Beysolow, M.D., M.P.H. Medical Officer National Center for Immunization and Respiratory.
Module 6 Inactivated poliovirus vaccine AEFI monitoring Training for Inactivated Poliovirus Vaccine (IPV) introduction.
RPMS Immunization Package Training - Reports Version 8.5*1 Amy Groom, MPH IHS Immunization Program Manager.
Common Childhood Diseases. Routine childhood immunization schedule Age at vaccination2 mos4 mos6 mos12 mos18 mos4-6 yrs9-13 yrs14-16 yrs Diptheria 8 Tetanus.
Vaccine Education Module: Vaccines Updated: April 2013.
Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.
Challenges:  Patient Age  Live virus or split virus  Preservative free or with preservative  Combo vaccine or individual vaccine  Route of administration.
Postmarketing Risk Assessment of Drug Products Division of Drug Risk Evaluation Office of Drug Safety Center for Drug Evaluation and Research.
ELIZABETH WILLIAMS, MD FELLOW IN VACCINOLOGY AND VACCINE SAFETY VANDERBILT UNIVERSITY AUGUST 30 TH, 2012 Thimerosal and Vaccine Safety.
Case Study: Jennifer and James Amy B. Middleman, MD, MSEd, MPH Assistant Professor, Department of Pediatrics, Adolescent Medicine Section, Baylor College.
Vaccine Safety Concerns  Past of vaccines  Now most parents have never seen a case of diphtheria, measles, or other once- common diseases.  They therefore.
Georgia Requirements for School and Childcare Attendance Presentation to: Presented by: Date:
Public Health Preventive Medicine primary prevention specific prevention immunization Samar Musmar,MD,FAAFP Consultant, family medicine Clinical assistant.
Childhood Immunization Update for WIC and Clerical Personnel Presented by: Date:
Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.
Vaccine Safety Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention Revised.
Jeff Neccuzi, Director Division of Immunization Services WV Bureau for Public Health.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.
{ THE HEALTH CENTER at Saint Xavier University.
TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.
Immunizations: 101 The Basics of Vaccine Administration
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 31 Health Supervision.
Medication/ Medication Administration
Responsibilities and Principles of Drug Administration
Economic Evaluation of Routine Childhood Immunization with DTaP, Hib, IPV, MMR and HepB Vaccines in the United States, 2001 Fangjun Zhou Health Services.
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
DEVELOPING EVIDENCE ON VACCINE SAFETY Susan S. Ellenberg, Ph.D. Center for Clinical Epidemiology and Biostatistics U Penn School of Medicine Global Vaccines.
 Radiopharmaceuticals are agents used to diagnose certain medical problems or treat certain diseases. They may be given to the patient in several different.
1 Vaccines and Related Biologic Products Advisory Committee (VRBPAC) May 16, 2007 FluMist ® Influenza Virus Vaccine Live, Intranasal Safety and Effectiveness.
Administering Injections and Immunizations
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
Core Topic 11 Documentation, record keeping and reporting.
8 Medication Errors and Prevention.
Preventing Vaccine Errors in the Real World: Providing Better Protection to Prevent Vaccine Preventable Diseases Cindy Schulte, RN, BSN VPD Surveillance.
Progress in adolescent vaccination coverage levels in the United States National Immunization Conference Washington, DC March 31, 2011 Shannon Stokley,
Vaccination Administration Errors Reported to the Vaccine Adverse Event Reporting System (VAERS) Elaine R. Miller, RN, MPH Beth Hibbs, RN, MPH Barbara.
1 Syncope and Related Injuries after Vaccination Wan-Ting Huang, MD Immunization Safety Office Office of the Chief Science Officer The 42 nd National Immunization.
National Immunization Conference March 30, 2011 Elaine R. Miller, RN, MPH Beth Hibbs, RN, MPH What Healthcare Providers Need to Know about the Vaccine.
1 Review of the Vaccine Adverse Event Reporting System (VAERS) Beth Hibbs RN, MPH; Elaine Miller RN, MPH Immunization Safety Office (ISO) Division of Healthcare.
Vaccination Info. Journal of immunology Vaccination of HCWs was associated with reductions in total patient mortality from 17% to 10% (odds ratio [OR],
Module 6 Monitoring Events Supposedly Attributable to Vaccination or Immunization (ESAVIs) Training for Inactivated Poliovirus Vaccine (IPV) introduction.
Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.
Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should.
Jennifer Rittenhouse Cope, MD EIS Officer North Dakota Department of Health Factors Associated with Tdap and Meningococcal Vaccination Coverage Among Middle.
Vaccine Preventable Diseases and Georgia Requirements for Child Care Attendance Presentation to: Presented by: Date:
TM Influenza Vaccine Safety in Children: Data from VAERS John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.

ACIP Recommendations Update for the U.S. Influenza Season
Chapter 36 Vaccines Copyright © 2015, 2012, 2009, 2006, 2003, 2000, 1997, 1993 by Saunders, an imprint of Elsevier Inc.
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Quadrivalent Human Papillomavirus Vaccine (HPV4) Adverse Events
Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.
8 Medication Errors and Prevention.
Adverse Event Analysis
Safety in Medication Administration
Immunization Safety Office (ISO) National Immunization Program (NIP)
Presentation transcript:

Beth Hibbs, RN, MPH Immunization Safety Office - Division Of Healthcare Quality Promotion, Centers for Disease Control and Prevention Vaccination Errors (Oops!) Reported to the Vaccine Adverse Event Reporting System (VAERS), National Immunization Conference 2012 The findings in this presentation are those of the authors and do not necessarily represent the official position of CDC or FDA

Overview  Background  Objective  Methods  Findings  Summary  Conclusions 2

Background Vaccination Errors  Institute of Medicine (IOM) reports focused national attention on medical errors a  MMWR –in past ten years, 3 notices on vaccination errors b  Increasing complexity of the immunization schedule a Preventing Medication Errors IOM 2007, b Notice to Readers: Inadvertent Intradermal Administration of Tetanus Toxoid--Containing Vaccines Instead of Tuberculosis Skin Tests MMWR 2004; * Inadvertent Misadministration of Meningococcal Conjugate Vaccine MMWR Sept 2006; *Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and a- cellular Pertussis Vaccines. (Page 27)* 3

Definitions  Vaccination Error  Any preventable event that may cause or lead to inappropriate use or patient harm. Such events may be related to professional practice, immunization products, (vials, needle, syringes), storage, dispensing and administration*  Vaccine Adverse Health Event  Health effects that occur after immunization that may or may not be causally related to the vaccine *CDC Immunization Safety Office, VAERS Medication Error Study workgroup. Adapted in part from U.S. Pharmacopeia (USP) medical error definition from 4

National Organizations that Accept Reports of Vaccination Errors  Vaccine Adverse Event Reporting System (VAERS)  Accepts reports about adverse events following immunization  MedWatch  Accepts reports about products regulated by the FDA, including drugs and medical devices  Institute for Safe Medication Practices (ISMP)  Medication Error Reporting Program (MERP) accepts reports related to med errors Some mistakes all the world can see….. Other errors need to be reported to better understand and prevent them 5

Vaccine Adverse Event Reporting System (VAERS)  Authorized by National Childhood Vaccine Injury Act of 1986  Jointly administered CDC and FDA  National, post-marketing, passive reporting system for adverse events occurring after receipt of US- licensed vaccines  Receives average ~33,000* reports/year ( ) *Numbers include both US and foreign reports, primary and non-primary 6

VAERS Studies of Vaccination Errors  an analysis of vaccination error reports a  49 total reports of vaccination errors in VAERS  Most frequent error were wrong vaccine given  42/49 adverse health events reported, most frequent was injection site reaction(12), fever (3) and irritability(3). Number of serious reports not reported.  follow up study of the report b  119 errors were reported to VAERS (26 actual or true errors)  76 were not actual errors (37 data entry errors, 30 reporter errors, 9 “off-label” use by prescribing physician)  The most frequent error was wrong vaccine given  A wide variety of adverse health events were reported (i.e. cellulitis, seizure, wheezing,). Number of serious reports not reported. a Varricchio F. Medication errors reported to the vaccine adverse event reporting system (VAERS). Vaccine Aug 19;20(25-26): b Varricchio F, Reed J; Follow-up study of medication errors reported to the vaccine adverse event reporting system (VAERS). South Med J May;99(5):

Objective  To describe the types and frequency of vaccination errors received by VAERS in the U.S  Description of selected findings  Rotavirus vaccine  trivalent influenza vaccine (TIV) 8

Methods  Search inclusion criteria:  All VAERS U.S. primary reports with a vaccination error code  Report receipt dates: 01/01/ /31/2011  Coded vaccination error and health events for VAERS reports using Medical Dictionary for Regulatory Activities (MedDRA) 39 MedDRA codes describing vaccination errors  Classified error reports into 11 error groups  Reviewed and characterized selected reports 9

Groupings of Vaccine Error Codes (n=11) Accidental ACCIDENTAL EXPOSURE ACCIDENTAL NEEDLE STICK Administration Errors DRUG ADMINISTERED AT INAPPROPRIATE SITE DRUG ADMINISTRATION ERROR INCORRECT DRUG DOSAGE FORM ADMINISTERED, INCORRECT DRUG ADMINSTRATION DURATION INCORRECT ROUTE OF DRUG ADMINISTRATION WRONG TECHNIQUE IN DRUG USAGE PROCESS Contraindication CONTRAINDICATION TO VACCINATION LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR Equipment INJURY ASSOCIATED WITH DEVICE MEDICAL DEVICE COMPLICATION General MEDICATION ERROR VACCINATION ERROR Inappropriate Schedule INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE Incorrect Dose ACCIDENTAL OVERDOSE DRUG DOSE OMISSION INCORRECT DOSE ADMINISTERED UNDERDOSE OVERDOSE MULTIPLE DRUG OVERDOSE Product Quality PRODUCT CONTAMINATION, PRODUCT CONTAMINATION PHYSICAL, PRODUCT QUALITY ISSUE, Product Labeling/Packaging DRUG NAME CONFUSION PRODUCT LABEL CONFUSION PRODUCT NAME CONFUSION PRODUCT CONTAINER ISSUE, PRODUCT LABEL ISSUE, PRODUCT LABEL ON WRONG PRODUCT, PRODUCT OUTER PACKAGING ISSUE, PRODUCT PACKAGING ISSUE, Storage and Dispensing DRUG DISPENSING ERROR EXPIRED DRUG ADMINISTERED INCORRECT PRODUCT STORAGE INCORRECT STORAGE OF DRUG POOR QUALITY DRUG ADMINISTERED Wrong Drug WRONG DRUG ADMINISTERED 10

VAERS Surveillance Definitions for “Serious” versus “Non-serious” Reports A check in box 8 of the VAERS form for these categories = “Serious" 11

Preliminary Findings Vaccination Errors VAERS Total VAERS reports 255,528 Vaccination error 13,137 (5.1%) Vaccination error with no other AE documented 8,813 (67.1%) Vaccination error with other AE documented 4,324 (32.9%) “Serious” reports 357 (2.7%) 12

Number and Percentage of Vaccine Error Reports and all VAERS reports,

a Some Groupings contain more than 1 MedDRA Code; Error groups are not mutually exclusive b Primary VAERS reports Vaccine Error Group a N% INAPPROPRIATE SCHEDULE WRONG DRUG ADMINISTERED GENERAL ERROR CODE STORAGE AND DISPENSING ISSUES ADMINISTRATION ERRORS INCORRECT DOSE ACCIDENTAL CONTRAINDICATION TO VACCINATION PRODUCT QUALITY EQUIPMENT600.5 PRODUCT LABELING&PACKAGING150.1 TOTAL b 13,137 Medical Error Groups reported to VAERS by Type of Error

Most Frequent Error Group: Inappropriate Schedule Errors Pediatric and Adult Vaccines,  Most common Pediatric vaccines  Rotavirus 24% (n=620)  Influenza inact. 19% (n=509)  DTaP 14% (n=369)  Pneumococcal 14% (n=365)  Most common Adult vaccines  HPV 22% (n=216)  Influenza nasal (H1N1) 15% (n=144)  Zoster 13% (n=131)  Tdap 11%(n=112) Age and Inappropriate Schedule Group Errors Age N % <6 mos mos yrs yrs yrs yrs yrs yrs.1714 Unknown2757 Total

Inappropriate Schedule Error Reports with Adverse Health Events,  1,209 (31.1%) reports with inappropriate schedule errors also reported an adverse event. 117 (9.7%) were “serious”  Most common adverse events  Fever15% (n=180)  Injection site erythema 9% (n=108)  Injection site pain 9% (n=106)  Most common Pediatric vaccines  DTaP24% (n=155)  HPV21% (n=136)  Rotavirus18% (n=118)  Most common Adult Vaccines  HPV 37% (n=192)  Zoster 22% (n=112)  DTaP 11% (n=57) Age and Inappropriate Schedule Group Errors Age N % <6 mos mos yrs yrs yrs yrs yrs yrs.484 Unknown454 Total 1,209 16

Second most frequently reported error: Wrong Vaccine Administered  Wrong Vaccine Administered 2693 (20.5%) of all error reports to VAERS Most Common Vaccine Types for Wrong Vaccine Reports VaccineN% Varicella61523 Zoster45417 DTaP45317 Tdap34713 Hepatitis A31112 Influenza inactivated Age and Wrong Vaccine Administered Group Error Age N % <6 mos mos yrs yrs yrs yrs yrs yrs.2048 Unknown3378 Total2,693

Wrong Vaccine Administered with Adverse Events,  532(19.8%) reports reported an AE; 25 (4.7%) of 532 were serious  Three most common adverse events  Fever 17% (n= 88)  Injection site erythema 16% (n=83)  Erythema 10% (n=55) Most Common Vaccine Types for Wrong Vaccine Reports VaccineN% DTAP13425 HPV7414 Influenza inactivated6512 PPV6212 Tdap5611 Zoster Age and Wrong Vaccine Administered Group Error Age N% <6 mos mos yrs yrs yrs yrs yrs yrs.204 Unknown448 Total532

Wrong Vaccine Administered “Mix-ups” for 100 Randomly Selected Reports  The most frequent vaccine combinations “mix-ups”  Varicella – Zostavax (n=25)  DTaP – Tdap (n=11)  Pneumovax – Prevnar (n=7)  10 reported an adverse health event:  Two serious reports (meningitis; otitis media/influenza)  Non-serious reports Injection site reaction (3) Fever (2) Respiratory (1) Constitutional symptoms (1) Allergic (1) 19

Eye Splashes and Rotavirus Vaccines *  25 reports of eye splash following administration of rotavirus vaccines  Infant coughing, sneezing or spitting the vaccine into eyes (n=20)  Eye splash by other means (n=4)  Unknown exposure route (n=1)  Persons Affected by Eye Splash:  Health Care Providers (80%); Patients (12%); Parents (8%)  Adverse health event affecting the eye (n=16)  All 16 occurred in health care providers  All were non-serious *Rotavirus vaccine was licensed in Error codes for accidental exposure and Grouped Eye MedDRA codes used in VAERS data analysis 20

Seasonal Trivalent Inactivated Influenza Vaccine (TIV) and Vaccine Administered at Inappropriate Site Errors,  89 reports of Vaccine Administration Group Errors  50 (56%) were Vaccine Administered at Inappropriate Site 49 (98%) reported an Adverse Health Event o Pain in extremity (43%); Injection site pain (37%); Pain (28%); Musculoskeletal pain (18 %); Injected limb mobility decreased (16%); Bursitis (10%) o Serious reports (n=2) (VAERS #443753)“Intense pain 8 hours after vaccination… Vaccine was administered high on the left shoulder.” The pain persisted for several weeks “MRI showed a split rotor cup” - surgery required (VAERS #447139)“shot given high in shoulder, extreme pain while receiving, Could not move or use arm immediately after shot” – ”surgery required for extreme inflammation” 21

TIV and Vaccine Administered at Inappropriate Site, cont (n=50)  41 (82%) vaccine was given “too high in the arm”  Duration of Pain and Symptoms of “too high” 26 (63%) stated pain and symptoms lasted more than one week o 18/26 stated pain lasted >3 weeks or “several weeks” 15 lasted < 1 week or did not document duration of pain  Location of Immunization for all inappropriate site reports  50% in retail settings; 20% in hospital or public health clinics; 8% in MD Offices; 8% employee health; 8% other and 6% unknown 22 *Adverse events symptoms are not mutually exclusive

Summary  Vaccination Error reports have increased in VAERS during the past 11 years from 0.07% to 9%  “Inappropriate Schedule of Vaccine Administration”  Most commonly reported error, especially among children  Two-thirds of vaccination error reports have no reported adverse health event  However, errors can affect cost, convenience, effectiveness, and confidence in vaccination programs  Potential areas for public health prevention/intervention  Wrong vaccine “mix-ups” more common between similar vaccines that are given to children and adults (Varicella-Zostavax, DTaP-Tdap)  Eye splashes and rotavirus vaccine  Inappropriate site—”too high in arm” and Influenza vaccines TIV 23

Vaccine Adverse Event Reporting System (VAERS) Limitations  Not designed to assess if vaccine caused an adverse event (AE)  Reporting bias (e.g. underreporting, stimulated reporting)  Coding practices can affect types and numbers of errors reported  Inconsistent data quality and completeness  Lack of unvaccinated comparison group  VAERS form not designed to collect complete information on vaccination errors Strengths  Rapid signal detection  Can detect rare adverse events  Generates hypotheses  Encourages reports from healthcare providers and accepts reports from patients and others  Data available to the public 24

Conclusions  Vaccination Errors are an important area in vaccine safety research and surveillance. Continued study will be key in understanding and developing strategies to prevent them.  Focus of continued study in VAERS:  Errors that may be associated with an adverse health outcome  Frequency of the vaccination error  Preventability of the vaccination error 25

Resources for Preventing Vaccination Errors  Proper Storage and Handling of Vaccines  Vaccine Storage and Handling Guide (tool kit under revision), Pink Book Chapter 5,   Identify Contraindications & Precautions  Immunization Screening Questionnaires,  Proper Vaccine Administration–Right patient, Right time, Right dose, Right route, Right drug*  General Recommendations on Immunization   Report Clinically Significant Vaccination Errors to VAERS  VAERS *The five rights of medication administration Nursing literature

Acknowledgements  Pedro Moro  Paige Lewis  Oidda Museru  Elaine Miller  Talia Yue  Theresa Harrington  Claudia Vellozzi  Karen Broder 27